Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

The effect of text messaging on latent tuberculosis treatment adherence: a randomised controlled trial.

Johnston JC, van der Kop ML, Smillie K, Ogilvie G, Marra F, Sadatsafavi M, Romanowski K, Budd MA, Hajek J, Cook V, Lester RT.

Eur Respir J. 2018 Feb 7;51(2). pii: 1701488. doi: 10.1183/13993003.01488-2017. Print 2018 Feb.

PMID:
29437940
2.

The effect of weekly text-message communication on treatment completion among patients with latent tuberculosis infection: study protocol for a randomised controlled trial (WelTel LTBI).

van der Kop ML, Memetovic J, Patel A, Marra F, Sadatsafavi M, Hajek J, Smillie K, Thabane L, Taylor D, Johnston J, Lester RT.

BMJ Open. 2014 Apr 9;4(4):e004362. doi: 10.1136/bmjopen-2013-004362.

3.

Screening for Latent Tuberculosis Infection in Adults: An Evidence Review for the U.S. Preventive Services Task Force [Internet].

Kahwati LC, Feltner C, Halpern M, Woodell CL, Boland E, Amick HR, Weber RP, Jonas DE.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Sep.

4.

Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.

Sharma SK, Sharma A, Kadhiravan T, Tharyan P.

Evid Based Child Health. 2014 Mar;9(1):169-294. doi: 10.1002/ebch.1962.

PMID:
25404581
5.

Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.

Belknap R, Holland D, Feng PJ, Millet JP, Caylà JA, Martinson NA, Wright A, Chen MP, Moro RN, Scott NA, Arevalo B, Miró JM, Villarino ME, Weiner M, Borisov AS; TB Trials Consortium iAdhere Study Team.

Ann Intern Med. 2017 Nov 21;167(10):689-697. doi: 10.7326/M17-1150. Epub 2017 Nov 7.

6.

Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial.

Liu X, Lewis JJ, Zhang H, Lu W, Zhang S, Zheng G, Bai L, Li J, Li X, Chen H, Liu M, Chen R, Chi J, Lu J, Huan S, Cheng S, Wang L, Jiang S, Chin DP, Fielding KL.

PLoS Med. 2015 Sep 15;12(9):e1001876. doi: 10.1371/journal.pmed.1001876. eCollection 2015 Sep.

7.

Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment.

Trajman A, Long R, Zylberberg D, Dion MJ, Al-Otaibi B, Menzies D.

Int J Tuberc Lung Dis. 2010 May;14(5):551-9.

PMID:
20392347
8.

Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan.

Huang YW, Yang SF, Yeh YP, Tsao TC, Tsao SM.

Medicine (Baltimore). 2016 Aug;95(34):e4126. doi: 10.1097/MD.0000000000004126.

9.

Promoting adherence to treatment for latent TB infection through mobile phone text messaging: study protocol for a pilot randomized controlled trial.

Oren E, Bell ML, Garcia F, Perez-Velez C, Gerald LB.

Pilot Feasibility Stud. 2017 Mar 13;3:15. doi: 10.1186/s40814-017-0128-9. eCollection 2017.

10.

Efficacy of a text messaging (SMS) based intervention for adults with hypertension: protocol for the StAR (SMS Text-message Adherence suppoRt trial) randomised controlled trial.

Bobrow K, Brennan T, Springer D, Levitt NS, Rayner B, Namane M, Yu LM, Tarassenko L, Farmer A.

BMC Public Health. 2014 Jan 11;14:28. doi: 10.1186/1471-2458-14-28.

11.

Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Kahwati LC, Feltner C, Halpern M, Woodell CL, Boland E, Amick HR, Weber RP, Jonas DE.

JAMA. 2016 Sep 6;316(9):970-83. doi: 10.1001/jama.2016.10357. Review.

PMID:
27599332
12.

Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study.

Goswami ND, Gadkowski LB, Piedrahita C, Bissette D, Ahearn MA, Blain ML, Østbye T, Saukkonen J, Stout JE.

BMC Public Health. 2012 Jun 21;12:468. doi: 10.1186/1471-2458-12-468.

13.

SIRCLE: a randomised controlled cost comparison of self-administered short-course isoniazid and rifapentine for cost-effective latent tuberculosis eradication.

Denholm JT, McBryde ES, Eisen D, Street A, Matchett E, Chen C, Shultz TR, Biggs B, Leder K.

Intern Med J. 2017 Dec;47(12):1433-1436. doi: 10.1111/imj.13601. Erratum in: Intern Med J. 2018 Apr;48(4):488.

PMID:
29224209
14.

Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.

Page KR, Sifakis F, Montes de Oca R, Cronin WA, Doherty MC, Federline L, Bur S, Walsh T, Karney W, Milman J, Baruch N, Adelakun A, Dorman SE.

Arch Intern Med. 2006 Sep 25;166(17):1863-70.

PMID:
17000943
15.

Three months of weekly rifapentine plus isoniazid for latent tuberculosis treatment in solid organ transplant candidates.

Knoll BM, Nog R, Wu Y, Dhand A.

Infection. 2017 Jun;45(3):335-339. doi: 10.1007/s15010-017-1004-5. Epub 2017 Mar 8.

PMID:
28276008
16.

Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection.

Holland DP, Sanders GD, Hamilton CD, Stout JE.

Am J Respir Crit Care Med. 2009 Jun 1;179(11):1055-60. doi: 10.1164/rccm.200901-0153OC. Epub 2009 Mar 19.

17.

Internet-accessed sexually transmitted infection (e-STI) testing and results service: A randomised, single-blind, controlled trial.

Wilson E, Free C, Morris TP, Syred J, Ahamed I, Menon-Johansson AS, Palmer MJ, Barnard S, Rezel E, Baraitser P.

PLoS Med. 2017 Dec 27;14(12):e1002479. doi: 10.1371/journal.pmed.1002479. eCollection 2017 Dec.

18.

Predictors of Latent Tuberculosis Infection Treatment After Introduction of a New Regimen: A Retrospective Cohort Study at an Inner City Clinic.

Yamin A, Bornstein E, Hensel R, Mohamed O, Kempker RR.

Open Forum Infect Dis. 2016 Apr 21;3(4):ofw082. eCollection 2016 Oct.

19.

Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].

LeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep.

20.

Completion of treatment for latent tuberculosis infection with monthly drug dispensation directly through the tuberculosis clinic.

Dobler CC, Marks GB.

PLoS One. 2012;7(11):e48900. doi: 10.1371/journal.pone.0048900. Epub 2012 Nov 5. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/4498fd07-acae-49bb-abf2-d2e914a249d0.

Supplemental Content

Support Center